These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1006 related articles for article (PubMed ID: 26253193)
1. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics. Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193 [TBL] [Abstract][Full Text] [Related]
2. Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008. Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Nygård JF Ann Surg Oncol; 2015 Nov; 22(12):3836-45. PubMed ID: 25743325 [TBL] [Abstract][Full Text] [Related]
3. Survival following breast-conserving therapy is equal to that following mastectomy in young women with early-stage invasive lobular carcinoma. Yu TJ; Liu YY; Hu X; Di GH Eur J Surg Oncol; 2018 Nov; 44(11):1703-1707. PubMed ID: 30029824 [TBL] [Abstract][Full Text] [Related]
4. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. Agarwal S; Pappas L; Neumayer L; Kokeny K; Agarwal J JAMA Surg; 2014 Mar; 149(3):267-74. PubMed ID: 24429935 [TBL] [Abstract][Full Text] [Related]
5. Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy. Laird J; Lok B; Siu C; Cahlon O; Khan AJ; McCormick B; Powell SN; Cody H; Wen HY; Ho A; Braunstein LZ Ann Surg Oncol; 2018 Jan; 25(1):154-163. PubMed ID: 29094250 [TBL] [Abstract][Full Text] [Related]
6. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast. Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636 [TBL] [Abstract][Full Text] [Related]
7. Surgical management of lobular carcinoma from a national screening program: a retrospective analysis. Sharma SD; Barry M; O'Reilly EA; Kell MR Eur J Surg Oncol; 2015 Jan; 41(1):79-85. PubMed ID: 25441933 [TBL] [Abstract][Full Text] [Related]
8. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114 [TBL] [Abstract][Full Text] [Related]
9. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer. Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341 [TBL] [Abstract][Full Text] [Related]
10. In the Modern Treatment Era, Is Breast Conservation Equivalent to Mastectomy in Women Younger Than 40 Years of Age? A Multi-Institution Study. Frandsen J; Ly D; Cannon G; Suneja G; Matsen C; Gaffney DK; Wright M; Kokeny KE; Poppe MM Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1096-103. PubMed ID: 26581146 [TBL] [Abstract][Full Text] [Related]
11. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients. Laurberg T; Alsner J; Tramm T; Jensen V; Lyngholm CD; Christiansen PM; Overgaard J Acta Oncol; 2017 Jan; 56(1):59-67. PubMed ID: 27846764 [TBL] [Abstract][Full Text] [Related]
12. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302 [TBL] [Abstract][Full Text] [Related]
13. Which eligible breast conservation patients choose mastectomy in the setting of newly diagnosed breast cancer? Adkisson CD; Bagaria SP; Parker AS; Bray JM; Gibson T; Thomas CS; Heckman MG; McLaughlin SA Ann Surg Oncol; 2012 Apr; 19(4):1129-36. PubMed ID: 21975859 [TBL] [Abstract][Full Text] [Related]
14. Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514 [TBL] [Abstract][Full Text] [Related]
15. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management. Tafra L; Essner R; Brenner RJ; Giuliano AE Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571 [TBL] [Abstract][Full Text] [Related]
16. Impact of local surgical treatment on survival in young women with T1 breast cancer: long-term results of a population-based cohort. Jeon YW; Choi JE; Park HK; Kim KS; Lee JY; Suh YJ Breast Cancer Res Treat; 2013 Apr; 138(2):475-84. PubMed ID: 23456232 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Oncological Safety of Fat Grafting After Breast-Conserving Therapy: A Prospective Study. Mestak O; Hromadkova V; Fajfrova M; Molitor M; Mestak J Ann Surg Oncol; 2016 Mar; 23(3):776-81. PubMed ID: 26467459 [TBL] [Abstract][Full Text] [Related]
18. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. McGuire KP; Santillan AA; Kaur P; Meade T; Parbhoo J; Mathias M; Shamehdi C; Davis M; Ramos D; Cox CE Ann Surg Oncol; 2009 Oct; 16(10):2682-90. PubMed ID: 19653046 [TBL] [Abstract][Full Text] [Related]
19. Left-Sided Breast Irradiation does not Result in Increased Long-Term Cardiac-Related Mortality Among Women Treated with Breast-Conserving Surgery. Paul Wright G; Drinane JJ; Sobel HL; Chung MH Ann Surg Oncol; 2016 Apr; 23(4):1117-22. PubMed ID: 26530446 [TBL] [Abstract][Full Text] [Related]
20. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology. Moran MS; Yang Q; Haffty BG Breast J; 2009; 15(6):571-8. PubMed ID: 19995377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]